Cargando…
No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe
BACKGROUND: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR. The controversial discussion about the virus being detected in PCA tissue, blood samples from patients sufferin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192048/ https://www.ncbi.nlm.nih.gov/pubmed/22022417 http://dx.doi.org/10.1371/journal.pone.0025592 |
_version_ | 1782213708093587456 |
---|---|
author | Stieler, Kristin Schindler, Sarah Schlomm, Thorsten Hohn, Oliver Bannert, Norbert Simon, Ronald Minner, Sarah Schindler, Michael Fischer, Nicole |
author_facet | Stieler, Kristin Schindler, Sarah Schlomm, Thorsten Hohn, Oliver Bannert, Norbert Simon, Ronald Minner, Sarah Schindler, Michael Fischer, Nicole |
author_sort | Stieler, Kristin |
collection | PubMed |
description | BACKGROUND: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR. The controversial discussion about the virus being detected in PCA tissue, blood samples from patients suffering from chronic fatigue syndrome (CFS), as well as from a significant number of healthy controls prompted us to deepen our studies about detection of XMRV infection applying different detection methods (PCR, cocultivation and immunohistochemistry [IHC]). METHODOLOGY/PRINCIPAL FINDINGS: Peripheral blood mononuclear cells (PBMCs) from 92 PCA and 7 healthy controls were isolated, PHA activated and cocultivated with LNCaP cells for up to 8 weeks. Supernatant of these cells was applied to a reporter cell line, DERSE-iGFP. Furthermore, the PBMCs and cocultivated LNCaP cells were tested for the presence of XMRV by PCR as well as Western Blot analysis. While all PCR amplifications and Western Blot analyses were negative for signs of XMRV infection, DERSE-iGFP cells displayed isolated GFP positive cells in three cases. In all three cases XMRV presence could not be confirmed by PCR technology. In addition, we performed XMRV specific IHC on PCA tissue sections. Whole tissue sections (n = 20), as well as tissue microarrays (TMA) including 50 benign prostate hyperplasia (BPH), 50 low grade and 50 high grade PCA sections and TMAs including breast cancer, colon cancer and normal tissues were stained with two XMRV specific antisera. XMRV protein expression was not detected in any cancer sections included. One BPH tissue displayed XMRV specific protein expression in random isolated basal cells. CONCLUSION: We were unable to conclusively detect XMRV in the blood from PCA patients or from healthy controls and there is no conclusive evidence of XMRV protein expression in PCA, breast cancer and colon cancer tissue sections tested by IHC staining. |
format | Online Article Text |
id | pubmed-3192048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-31920482011-10-21 No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe Stieler, Kristin Schindler, Sarah Schlomm, Thorsten Hohn, Oliver Bannert, Norbert Simon, Ronald Minner, Sarah Schindler, Michael Fischer, Nicole PLoS One Research Article BACKGROUND: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR. The controversial discussion about the virus being detected in PCA tissue, blood samples from patients suffering from chronic fatigue syndrome (CFS), as well as from a significant number of healthy controls prompted us to deepen our studies about detection of XMRV infection applying different detection methods (PCR, cocultivation and immunohistochemistry [IHC]). METHODOLOGY/PRINCIPAL FINDINGS: Peripheral blood mononuclear cells (PBMCs) from 92 PCA and 7 healthy controls were isolated, PHA activated and cocultivated with LNCaP cells for up to 8 weeks. Supernatant of these cells was applied to a reporter cell line, DERSE-iGFP. Furthermore, the PBMCs and cocultivated LNCaP cells were tested for the presence of XMRV by PCR as well as Western Blot analysis. While all PCR amplifications and Western Blot analyses were negative for signs of XMRV infection, DERSE-iGFP cells displayed isolated GFP positive cells in three cases. In all three cases XMRV presence could not be confirmed by PCR technology. In addition, we performed XMRV specific IHC on PCA tissue sections. Whole tissue sections (n = 20), as well as tissue microarrays (TMA) including 50 benign prostate hyperplasia (BPH), 50 low grade and 50 high grade PCA sections and TMAs including breast cancer, colon cancer and normal tissues were stained with two XMRV specific antisera. XMRV protein expression was not detected in any cancer sections included. One BPH tissue displayed XMRV specific protein expression in random isolated basal cells. CONCLUSION: We were unable to conclusively detect XMRV in the blood from PCA patients or from healthy controls and there is no conclusive evidence of XMRV protein expression in PCA, breast cancer and colon cancer tissue sections tested by IHC staining. Public Library of Science 2011-10-12 /pmc/articles/PMC3192048/ /pubmed/22022417 http://dx.doi.org/10.1371/journal.pone.0025592 Text en Stieler et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Stieler, Kristin Schindler, Sarah Schlomm, Thorsten Hohn, Oliver Bannert, Norbert Simon, Ronald Minner, Sarah Schindler, Michael Fischer, Nicole No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe |
title | No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe |
title_full | No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe |
title_fullStr | No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe |
title_full_unstemmed | No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe |
title_short | No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe |
title_sort | no detection of xmrv in blood samples and tissue sections from prostate cancer patients in northern europe |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192048/ https://www.ncbi.nlm.nih.gov/pubmed/22022417 http://dx.doi.org/10.1371/journal.pone.0025592 |
work_keys_str_mv | AT stielerkristin nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope AT schindlersarah nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope AT schlommthorsten nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope AT hohnoliver nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope AT bannertnorbert nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope AT simonronald nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope AT minnersarah nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope AT schindlermichael nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope AT fischernicole nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope |